{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:11:02Z","timestamp":1787317862761,"version":"build-2736575974"},"reference-count":157,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.semnephrol.2016.10.009","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T22:46:37Z","timestamp":1485816397000},"page":"77-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Peritoneal Membrane Preservation"],"prefix":"10.1016","volume":"37","author":[{"given":"M. Auxiliadora","family":"Bajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"del Peso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Teitelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2016.10.009_bib1","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1177\/089686080002004S03","article-title":"Pathophysiology of peritoneal membrane failure","volume":"20","author":"Krediet","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0272-6386(12)80814-6","article-title":"Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study","volume":"23","author":"Selgas","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/oxfordjournals.ndt.a027318","article-title":"Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis","volume":"11","author":"Davies","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ki.1991.182","article-title":"Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929","volume":"40","author":"Wieslander","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2215\/CJN.03630807","article-title":"Peritoneal Biopsy Study Group of the Japanese Society for Peritoneal Dialysis. Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology","volume":"3","author":"Honda","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease","volume":"13","author":"Williams","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.prp.2008.01.014","article-title":"Tissue distribution of hyalinazing vasculopathy lesions in peritoneal dialysis patients. An autopsy study","volume":"204","author":"Jim\u00e9nez-Heffernan","year":"2008","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3747\/pdi.2011.00205","article-title":"Diabetes influences peritoneal morphology in uremic patients at the initiation of peritoneal dialysis","volume":"33","author":"Mizumasa","year":"2013","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/089686080502500113","article-title":"Ultrafiltration and small solute transport at initiation of PD: questioning the paradigm of peritoneal function","volume":"25","author":"Selgas","year":"2005","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1053\/j.ajkd.2003.11.010","article-title":"Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients","volume":"43","author":"Rumpsfeld","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib11","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/j.1523-1755.2005.00357.x","article-title":"Genetic and clinical factor influence the baseline permeability of the peritoneal membrane","volume":"67","author":"Gillerot","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000071429","article-title":"Assessment of comorbidity in peritoneal dialysis patients","volume":"140","author":"Davies","year":"2003","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib13","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1093\/ndt\/gfg318","article-title":"Is malnutrition an independent predictor of mortality in peritoneal dialysis patients?","volume":"18","author":"Chung","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ndt\/gfl529","article-title":"Inherent high peritoneal transport and ultrafiltration deficiency: their mid-term clinical relevance","volume":"22","author":"Fern\u00e1ndez-Reyes","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib15","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/j.1523-1755.2004.66021.x","article-title":"Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients","volume":"66","author":"Davies","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib16","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3747\/pdi.2011.00137","article-title":"The influence of initial peritoneal transport characteristics, inflammation, and high glucose exposure on prognosis for peritoneal membrane function","volume":"32","author":"Fern\u00e1ndez-Reyes","year":"2012","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib17","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/ki.1994.226","article-title":"A prospective study of peritoneal transport in CAPD patients","volume":"45","author":"Struijk","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib18","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/ndt\/16.11.2240","article-title":"Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis","volume":"16","author":"Chung","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib19","first-page":"3","article-title":"Changes in peritoneal membrane transport rates in patients on long term CAPD","volume":"5","author":"Blake","year":"1989","journal-title":"Adv Perit Dial"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib20","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/ndt\/gfi344","article-title":"Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up","volume":"21","author":"Clerbaux","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib21","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1681\/ASN.V471466","article-title":"Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients","volume":"4","author":"Lo","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib22","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/ndt\/gfh793","article-title":"Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor","volume":"20","author":"Del Peso","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/089686080002000210","article-title":"The longitudinal effect of a single peritonitis episode on peritoneal membrane transport in CAPD patients","volume":"20","author":"Ates","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/ki.2013.190","article-title":"The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients","volume":"84","author":"Cho","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib25","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1523-1755.2004.00747.x","article-title":"The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane","volume":"66","author":"Williams","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib26","first-page":"49","article-title":"Peritoneal functional changes induced by dialysate containing bicarbonate instead of lactate","volume":"12","author":"Selgas","year":"1996","journal-title":"Adv Perit Dial"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/089686080802800108","article-title":"Comparison between bicarbonate\/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study","volume":"28","author":"Fang","year":"2008","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib28","series-title":"Inflammation and chronic disease","first-page":"89","article-title":"Peritoneal inflammation and fibrosis in peritoneal dialysis","author":"Jim\u00e9nez-Heffernan","year":"2006"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa020809","article-title":"Peritoneal dialysis induces an epithelial-mesenchymal transition of mesothelial cells","volume":"348","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1681\/ASN.2004060436","article-title":"Transient overexpression of TGF-\u03b21 induces epithelial mesenchymal transition in the rodent peritoneum","volume":"16","author":"Margetts","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ki.1997.22","article-title":"Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD","volume":"51","author":"Nakayama","year":"1997","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2016.10.009_bib32","first-page":"S19","article-title":"Neoangiogenesis in the peritoneal membrane","volume":"20","author":"Krediet","year":"1999","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/089686089901900605","article-title":"Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis","volume":"19","author":"Mateijsen","year":"1999","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib34","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1038\/sj.ki.5002598","article-title":"Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport","volume":"108","author":"Del Peso","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib35","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/ndt\/gfl054","article-title":"Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients","volume":"21","author":"Sherif","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib36","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/089686080302300604","article-title":"Basic mechanisms and clinical implications of peritoneal fibrosis","volume":"23","author":"Margetts","year":"2003","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib37","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.ajkd.2005.08.011","article-title":"Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor","volume":"46","author":"Aroeira","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/089686080602600103","article-title":"Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure","volume":"26","author":"L\u00f3pez-Cabrera","year":"2006","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib39","first-page":"168","article-title":"Consequences of peritonitis episodes appearing late during peritoneal dialysis (PD) in patients able to continue PD","volume":"14","author":"Selgas","year":"1998","journal-title":"Adv Perit Dial"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib40","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.V1251046","article-title":"Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis","volume":"12","author":"Davies","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ki.1995.36","article-title":"Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis","volume":"47","author":"Witowski","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib42","first-page":"37","article-title":"Effect of bicarbonate\/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo","volume":"17","author":"Bajo","year":"2001","journal-title":"Adv Perit Dial"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib43","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1046\/j.1523-1755.2001.59780042.x","article-title":"Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties","volume":"78","author":"Plum","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib44","first-page":"185","article-title":"Peritoneal sclerosis-an overview","volume":"15","author":"Garosi","year":"1999","journal-title":"Adv Perit Dial"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2016.10.009_bib45","first-page":"S5","article-title":"Atlas of peritoneal histology","volume":"20","author":"Di Paolo","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.ajkd.2013.01.031","article-title":"Current status and practical use of effluent biomarkers in peritoneal dialysis patients","volume":"62","author":"Lopes Barreto","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib47","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/089686089401400207","article-title":"Dialysate cancer antigen (CA) 125 is a reflection of peritoneal cell mass in CAPD patients","volume":"14","author":"Koomen","year":"1994","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib48","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ki.1997.125","article-title":"Longitudinal follow-up of CA125 in peritoneal effluent","volume":"51","author":"Ho-dac-Pannekeet","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib49","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ndt\/17.8.1480","article-title":"Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate","volume":"17","author":"Pecoits-Filho","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib50","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/089686080102100605","article-title":"Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis","volume":"21","author":"Krediet","year":"2001","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/089686080602600109","article-title":"Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis","volume":"26","author":"Pecoits-Filho","year":"2006","journal-title":"Perit Dial Int"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2016.10.009_bib52","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1177\/089686080102103S17","article-title":"Bicarbonate\/Lactate Study Group. Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate\/lactate-based peritoneal dialysis solutions","volume":"21","author":"Cooker","year":"2001","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib53","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2362.2010.02353.x","article-title":"CCL18 in peritoneal dialysis patients and encapsulating peritoneal sclerosis","volume":"40","author":"Ahmad","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib54","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/ndt\/gfq771","article-title":"Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis","volume":"26","author":"Bell\u00f3n","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib55","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/ndt\/gfq593","article-title":"Matrix metalloproteinase levels in the drained dialysate reflect the peritoneal solute transport rate: a multicentre study in Japan","volume":"26","author":"Hirahara","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib56","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3747\/pdi.2012.01063","article-title":"Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients?","volume":"33","author":"Lopes Barreto","year":"2013","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib57","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-2143(99)90116-6","article-title":"The growth factors VEGF and TGF-beta1 in peritoneal dialysis","volume":"134","author":"Zweers","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1067\/mlc.2001.112235","article-title":"Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up","volume":"137","author":"Zweers","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib59","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1681\/ASN.V1281734","article-title":"Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane","volume":"12","author":"De Vriese","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3747\/pdi.2010.00200","article-title":"Activation of p38 mitogen-activated protein kinase promotes peritoneal fibrosis by regulating fibrocytes","volume":"32","author":"Kokubo","year":"2012","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib61","doi-asserted-by":"crossref","first-page":"F721","DOI":"10.1152\/ajprenal.00368.2009","article-title":"Connective tissue growth factor (CTGF\/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate","volume":"298","author":"Mizutani","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/089686089901900210","article-title":"Intraperitoneal hyaluronan production in stable continuous ambulatory peritoneal dialysis patients","volume":"19","author":"Yamagata","year":"1999","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib63","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1523-1755.2001.00497.x","article-title":"Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products","volume":"59","author":"Rippe","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib64","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1093\/ndt\/gfr662","article-title":"Proof-of-principle study to detect metabolic changes in peritoneal dialysis effluent in patients who develop encapsulating peritoneal sclerosis","volume":"27","author":"Dunn","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib65","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1681\/ASN.V12122775","article-title":"Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate\/lactate-buffered solution","volume":"12","author":"Hekking","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib66","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1681\/ASN.V981499","article-title":"Bicarbonate\/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNF-alpha secretion","volume":"9","author":"Mackenzie","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib67","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1744-9987.2007.00431.x","article-title":"Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model","volume":"1","author":"Kim","year":"2007","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib68","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ndt\/gfq357","article-title":"Low-GDP peritoneal dialysis fluid (\u05f3balance\u05f3) has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid","volume":"26","author":"Bajo","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib69","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3747\/pdi.2010.00315","article-title":"Influence of bicarbonate\/low-GDP peritoneal dialysis fluid (BicaVera) on in vitro and ex vivo epithelial-to-mesenchymal transition of mesothelial cells","volume":"32","author":"Fern\u00e1ndez-Perp\u00e9n","year":"2012","journal-title":"Perit Dial Int"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2016.10.009_bib70","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1681\/ASN.V13suppl_1s97","article-title":"Continuous dialysis with bicarbonate\/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function","volume":"13","author":"Jones","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib71","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000256658","article-title":"Impact of low glucose degradation product carbonate\/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum","volume":"31","author":"Oh","year":"2010","journal-title":"Am J Nephrol"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2016.10.009_bib72","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1177\/089686080502503S06","article-title":"The effect of low glucose degradation product dialysis solution on epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis patients","volume":"25","author":"Do","year":"2005","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib73","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1159\/000084110","article-title":"Effects of neutral pH and reduced glucose degradation products in a new peritoneal dialysis solution on morphology of peritoneal membrane in rats","volume":"100","author":"Ikehara","year":"2005","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib74","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/089686080702700120","article-title":"Long-term effect of peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration on peritoneum: a case report","volume":"27","author":"Shimizu","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib75","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3747\/pdi.2010.00234","article-title":"Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan","volume":"32","author":"Ayuzawa","year":"2012","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib76","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3747\/pdi.2011.00270","article-title":"Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis","volume":"33","author":"Kawanishi","year":"2013","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib77","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3747\/pdi.2014.00038","article-title":"Biocompatible dialysis solutions preserve peritoneal mesothelial cell and vessel wall integrity. A case-control study on human biopsies","volume":"36","author":"Del Peso","year":"2016","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000334151","article-title":"Novel peritoneal dialysis solutions--what are the clinical implications?","volume":"33","author":"J\u00f6rres","year":"2012","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib79","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/089686080002000627","article-title":"Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo","volume":"20","author":"Bajo","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib80","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/039139880703001207","article-title":"Comparison of icodextrin- and glucose-based peritoneal dialysis fluids in their acute and chronic effects on human peritoneal mesothelial cells","volume":"30","author":"Bender","year":"2007","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib81","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1523-1755.2005.00243.x","article-title":"Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription","volume":"67","author":"Davies","year":"2005","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2016.10.009_bib82","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1177\/089686080002002S08","article-title":"Strategies to reduce glucose exposure in peritoneal dialysis patients","volume":"20","author":"Holmes","year":"2000","journal-title":"Perit Dial Int"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2016.10.009_bib83","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1177\/089686080502503S16","article-title":"Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious","volume":"25","author":"Le Poole","year":"2005","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib84","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3747\/pdi.2014.00125","article-title":"Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers","volume":"35","author":"Yung","year":"2015","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib85","first-page":"56","article-title":"Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure","volume":"9","author":"De Alvaro","year":"1993","journal-title":"Adv Perit Dial"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib86","first-page":"78","article-title":"Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis","volume":"18","author":"Rodrigues","year":"2002","journal-title":"Adv Perit Dial"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib87","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3747\/pdi.2013.00286","article-title":"Peritoneal resting with heparinized lavage reverses peritoneal type I membrane failure. A comparative study of the resting effects on normal membranes","volume":"34","author":"De Sousa","year":"2014","journal-title":"Perit Dial Int"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2016.10.009_bib88","doi-asserted-by":"crossref","first-page":"S384","DOI":"10.1177\/089686089901902S62","article-title":"Effects of peritoneal rest on peritoneal transport and peritoneal membrane thickening in continuous ambulatory peritoneal dialysis in rats","volume":"19","author":"Kim","year":"1999","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib89","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/ndt\/gfh559","article-title":"Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats","volume":"20","author":"Zareie","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ki.2010.90","article-title":"The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?","volume":"78","author":"Nessim","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib91","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/089686080502500110","article-title":"Angiotensin II mediates high glucose-inducedTGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species","volume":"25","author":"Noh","year":"2005","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib92","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/089686080702700213","article-title":"ACE inhibitor and AT1-receptorblocker attenuate the production of VEGF in mesothelial cells","volume":"27","author":"Sauter","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib93","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/089686080102100221","article-title":"Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution?","volume":"21","author":"Duman","year":"2001","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib94","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/039139880502800212","article-title":"Effect of valsartan versus lisinopril on peritoneal sclerosis in rats","volume":"28","author":"Duman","year":"2005","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib95","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/089686080702700410","article-title":"The effects of irbesartan and spironolactone in prevention of peritoneal fibrosis in rats","volume":"27","author":"Ersoy","year":"2007","journal-title":"Perit Dial Int"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2016.10.009_bib96","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1177\/089686080802803s17","article-title":"Role of the renin-angiotensin system in the pathogenesis of peritoneal fibrosis","volume":"28","author":"Nakamoto","year":"2008","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib97","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1440-1797.2009.01162.x","article-title":"Effect of renin\u2013angiotensin system inhibitors on prevention of peritoneal fibrosis in peritoneal dialysis patients","volume":"15","author":"Jing","year":"2010","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib98","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/089686080702700413","article-title":"Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients","volume":"27","author":"Kolesnyk","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib99","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/ndt\/gfn421","article-title":"A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients","volume":"24","author":"Kolesnyk","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2016.10.009_bib100","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1177\/089686080702702s18","article-title":"Glycosaminoglycans and proteoglycans: overlooked entities?","volume":"27","author":"Yung","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib101","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0272-6386(86)80190-1","article-title":"Analysis of selected plasma constituents in continuous ambulatory peritoneal dialysis effluent","volume":"7","author":"Staprans","year":"1986","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib102","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1093\/ndt\/gfp440","article-title":"Altering peritoneal membrane function: removing the GAG?","volume":"24","author":"Fraser","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib103","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/089686080902900102","article-title":"Heparin and the peritoneal membrane","volume":"29","author":"Margetts","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib104","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0165-6147(00)89022-7","article-title":"Therapeutic uses of heparin beyond its traditional role as an anticoagulant","volume":"16","author":"Tyrell","year":"1995","journal-title":"Trends Pharmacol Sci"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2016.10.009_bib105","doi-asserted-by":"crossref","first-page":"S354","DOI":"10.1177\/089686080102103S65","article-title":"Non anticoagulant effects of heparin: implications for animal models of peritoneal dialysis","volume":"21","author":"De Vriese","year":"2001","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib106","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/157016309789869001","article-title":"Therapeutic use of heparin beyond anticoagulation","volume":"6","author":"Ludwig","year":"2009","journal-title":"Curr Drug Discov Technol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib107","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/ndt\/16.3.669","article-title":"Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis","volume":"16","author":"Pawlaczyk","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib108","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/089686080502500416","article-title":"Low molecular weight heparin improves peritoneal ultrafiltration and blocks complement and coagulation","volume":"25","author":"Bazargani","year":"2005","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib109","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/089686080902900105","article-title":"Long-term intervention with heparins in a rat model of peritoneal dialysis","volume":"29","author":"Schilte","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/089686089901900413","article-title":"Effect of intraperitoneal administration of heparin on advanced glycation end-products in CAPD","volume":"19","author":"Mizuiri","year":"1999","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib111","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/ndt\/gfh065","article-title":"Intraperitoneal heparin reduces peritoneal permeability and increases ultrafiltration in peritoneal dialysis patients","volume":"19","author":"Sj\u00f8land","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib112","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/ndt\/gfr546","article-title":"Effect of self-administered intraperitoneal bemiparin on peritoneal transport and ultrafiltration capacity in peritoneal dialysis patients with membrane dysfunction. A randomized, multi-centre open clinical trial","volume":"27","author":"Del Peso","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib113","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/ki.1996.446","article-title":"IL-1b, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD","volume":"50","author":"Yung","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib114","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/089686089801800406","article-title":"Role of peritoneal mesothelial cells and fibroblasts in the synthesis of hyaluronan during peritoneal dialysis","volume":"18","author":"Breborowicz","year":"1998","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib115","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/089686089601600410","article-title":"Synthesis of hyaluronic acid by human peritoneal mesothelial cells: effect of cytokines and dialysate","volume":"16","author":"Breborowicz","year":"1996","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib116","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ki.1994.304","article-title":"The source and possible significance of hyaluronan in the peritoneal cavity","volume":"46","author":"Yung","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib117","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/ajkd.2001.22086","article-title":"Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats","volume":"37","author":"Breborowicz","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib118","doi-asserted-by":"crossref","first-page":"180594","DOI":"10.1155\/2011\/180594","article-title":"Pathophysiology of the peritoneal membrane during peritoneal dialysis: the role of hyaluronan","volume":"2011","author":"Yung","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib119","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1046\/j.1523-1755.2000.00946.x","article-title":"Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats","volume":"57","author":"Po\u0142ubinska","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib120","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1523-1755.1998.00773.x","article-title":"Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume","volume":"53","author":"Wang","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib121","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/089686080302300109","article-title":"Effects of intraperitoneal hyaluronan on peritoneal fluid and solute transport in peritoneal dialysis patients","volume":"23","author":"Moberly","year":"2003","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib122","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1046\/j.1523-1755.2001.0590041529.x","article-title":"Bicarbonate\/Lactate Study Group. Bicarbonate\/lactate\u2013based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels","volume":"59","author":"Jones","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1128(199801)18:1<1::AID-MED1>3.0.CO;2-4","article-title":"Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide","volume":"18","author":"Harenberg","year":"1998","journal-title":"Med Res Rev"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib124","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(95)91506-0","article-title":"Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis","volume":"346","author":"Bazzato","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(99)70264-7","article-title":"Glycosaminoglycans prevent the functional and morphological peritoneal derangement in an experimental model of peritoneal fibrosis","volume":"33","author":"Fracasso","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib126","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/ndt\/gfr370","article-title":"Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion","volume":"27","author":"Pletinck","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib127","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1681\/ASN.2010111197","article-title":"Blocking TGF-\u03b21 protects the peritoneal membrane from dialysate-induced damage","volume":"22","author":"Loureiro","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib128","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jb\/mvq043","article-title":"Cellular and molecular basis for the regulation of inflammation by TGF-\u03b2","volume":"147","author":"Yoshimura","year":"2010","journal-title":"J Biochem"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib129","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1681\/ASN.2008040424","article-title":"HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium","volume":"20","author":"Yu","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib130","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ndt\/gfp618","article-title":"BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure","volume":"25","author":"Loureiro","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib131","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000322255","article-title":"Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis","volume":"31","author":"Huang","year":"2011","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib132","doi-asserted-by":"crossref","first-page":"e61165","DOI":"10.1371\/journal.pone.0061165","article-title":"Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis","volume":"8","author":"Loureiro","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib133","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/ndt\/gfq362","article-title":"Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study","volume":"26","author":"Korte","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib134","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3747\/pdi.2012.00286","article-title":"Can EPS development be avoided with early interventions? The potential role of tamoxifen--a single-center study","volume":"34","author":"De Sousa-Amorim","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib135","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ki.2008.231","article-title":"Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease","volume":"74","author":"Fried","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib136","doi-asserted-by":"crossref","first-page":"e109628","DOI":"10.1371\/journal.pone.0109628","article-title":"The effect of statin on epithelial-mesenchymal transition in peritoneal mesothelial cells","volume":"9","author":"Chang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib137","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1046\/j.1523-1755.2003.t01-2-00004.x","article-title":"Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells","volume":"63","author":"Haslinger","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib138","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1681\/ASN.2013101128","article-title":"Dynamic O-linked N-acetylglucosamine modification of proteins affects stress responses and survival of mesothelial cells exposed to peritoneal dialysis fluids","volume":"25","author":"Herzog","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib139","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/ndt\/gfr459","article-title":"Alanyl-glutamine dipeptide restores the cytoprotective stress proteome of mesothelial cells exposed to peritoneal dialysis fluids","volume":"27","author":"Kratochwill","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2016.10.009_bib140","first-page":"S72","article-title":"First clinical evidence for peritoneal immune-modulation by an alanyl-glutamine containing peritoneal dialysis solution","volume":"24","author":"Kratochwill","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib141","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/039139880502800215","article-title":"Prevention of peritoneal sclerosis: a new proposal to substitute glucose with carnitine dialysis solution (biocompatibility testing in vitro and in rabbits)","volume":"28","author":"Gaggiotti","year":"2005","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib142","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/ki.2011.117","article-title":"L-carnitine is an osmotic agent suitable for peritoneal dialysis","volume":"80","author":"Bonomini","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib143","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/089686080902900216","article-title":"Evaluation of taurine as an osmotic agent for peritoneal dialysis solution","volume":"29","author":"Nishimura","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib144","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3747\/pdi.2011.00332","article-title":"Pharmacologic targets and peritoneal membrane remodeling","volume":"34","author":"Farhat","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib145","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jcpt.12318","article-title":"Preserving the peritoneal membrane in long-term peritoneal dialysis patients","volume":"40","author":"Ditsawanon","year":"2015","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib146","doi-asserted-by":"crossref","first-page":"7908","DOI":"10.1038\/sj.onc.1203286","article-title":"The role of cyclooxygenases in inflammation, cancer, and development","volume":"18","author":"Williams","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib147","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1681\/ASN.2008020211","article-title":"Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane","volume":"20","author":"Aroeira","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib148","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1093\/ndt\/gfp384","article-title":"Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis","volume":"24","author":"Fabbrini","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib149","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib150","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/ndt\/gfq313","article-title":"The expanding spectrum of biological actions of vitamin D","volume":"25","author":"Rojas-Rivera","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib151","doi-asserted-by":"crossref","first-page":"e108477","DOI":"10.1371\/journal.pone.0108477","article-title":"Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production","volume":"9","author":"Gonz\u00e1lez-Mateo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib152","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5414\/CN107570","article-title":"Changes in peritoneal membrane permeability and proteinuria in patients on peritoneal dialysis after treatment with paricalcitol \u2212 a preliminary study","volume":"78","author":"Coronel","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib153","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.164.3.1364","article-title":"The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses","volume":"164","author":"Clark","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib154","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/labinvest.2010.111","article-title":"PPAR-gamma agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage","volume":"90","author":"Sandoval","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib155","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nm834","article-title":"Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy","volume":"9","author":"Hammes","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib156","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/dmrr.860","article-title":"Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro","volume":"24","author":"Schmid","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.semnephrol.2016.10.009_bib157","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1681\/ASN.2010070750","article-title":"Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis","volume":"22","author":"Kihm","year":"2011","journal-title":"J Am Soc Nephrol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516301048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516301048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T21:59:10Z","timestamp":1658527150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929516301048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":157,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0270929516301048"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.10.009","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peritoneal Membrane Preservation","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}